Similar to MDM2, MDM4 has also been shown to be amplified in a subset of gliomas [13] further indicating that amplification and overexpression of MDM2 and MDM4 may be an alternative molecular mechanism by which a subset of human malignant gliomas escapes from TP53-regulated growth control. Here, TP53 is linked to central nervous system cancer.